NEW YORK ( TheStreet) -- Omnicare (NYSE: OCR) hit a new 52-week high Tuesday as it is currently trading at $36.28, above its previous 52-week high of $36.26 with 709,218 shares traded as of 10:35 a.m. ET. Average volume has been 1.8 million shares over the past 30 days. Omnicare has a market cap of $3.79 billion and is part of the services sector and wholesale industry. Shares are up 2.8% year to date as of the close of trading on Monday. Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. The company has a P/E ratio of 25.2, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Omnicare as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full Omnicare Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.